Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

ASPN PEER ANALYSIS

Aspen Aerogels Inc — metric-by-metric comparison with peers and the industry median

ASPNAspen Aerogels Inc

🇺🇸 USA · NYSE · Industrials · Building Products & Equipment

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Building Products & Equipment

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
ASPNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
ASPN-26.3%EGPRO+95.0%MEGMT+174.2%KBORU+115.9%KLSER-9.9%QUAGR-41.7%
Year-to-Date (YTD)
ASPN+83.4%EGPRO+54.6%MEGMT+34.1%KBORU+85.2%KLSER-2.6%QUAGR+26.0%
1-Year
Split-adjusted
ASPN-26.3%SWIM-12.8%JBI-42.4%NX-18.9%APOG-6.8%LMB-46.2%
Year-to-Date (YTD)
ASPN+83.4%SWIM-7.4%JBI-21.6%NX+5.0%APOG+7.0%LMB-0.9%

Key Metric Comparison

P/E

Lower is better
ASPN—EGPRO15.17MEGMT10.77KBORU24.12KLSER—QUAGR—Median 24.76

ROE

Higher is better
ASPN-42.4%EGPRO15.8%MEGMT42.4%KBORU15.4%KLSER-43.4%QUAGR-11.8%Median 8.1%

Net Margin

Higher is better
ASPN-48.6%EGPRO10.0%MEGMT6.8%KBORU10.7%KLSER-19.0%QUAGR-10.0%Median 4.9%

Revenue Growth

Higher is better
ASPN-47.3%EGPRO7.0%MEGMT8.4%KBORU25.9%KLSER25.4%QUAGR7.8%Median 5.1%

P/E

Lower is better
ASPN—SWIM80.37JBI16.48NX—APOG12.05LMB28.02Median 24.76

ROE

Higher is better
ASPN-42.4%SWIM2.2%JBI7.9%NX-29.7%APOG13.8%LMB18.6%Median 8.1%

Net Margin

Higher is better
ASPN-48.6%SWIM1.5%JBI4.8%NX-13.9%APOG4.9%LMB5.1%Median 4.9%

Revenue Growth

Higher is better
ASPN-47.3%SWIM8.3%JBI-2.5%NX14.2%APOG1.8%LMB22.5%Median 5.1%

All Metrics

Valuation
MetricASPNEGPROMEGMTKBORUKLSERQUAGRInd. Median
P/E—15.1710.77●24.12——24.76
P/B2.012.034.173.142.100.95●2.49
EV/EBITDA—6.27●16.6231.13102.8010.0715.06
P/S1.861.510.74●2.590.850.871.51
Financial Health
MetricASPNEGPROMEGMTKBORUKLSERQUAGRInd. Median
Current Ratio2.88●1.411.071.300.820.991.54
Debt/Equity60.3%8.0%●149.4%84.6%115.3%41.2%57.7%
NetDebt/EBITDA0.79-0.17●3.445.4034.372.941.72
Profitability
MetricASPNEGPROMEGMTKBORUKLSERQUAGRInd. Median
Net Margin-48.6%10.0%6.8%10.7%●-19.0%-10.0%4.9%
ROE-42.4%15.8%42.4%●15.4%-43.4%-11.8%8.1%
ROA-23.2%8.6%13.4%●6.6%-15.8%-5.6%3.6%
EBITDA Margin-25.8%23.5%●5.6%10.1%1.2%12.2%12.2%
Growth + Dividend
MetricASPNEGPROMEGMTKBORUKLSERQUAGRInd. Median
Rev. Growth-47.3%7.0%8.4%25.9%●25.4%7.8%5.1%
NI Growth—32.3%207.8%●-25.2%——-5.3%
Div. Yield—2.9%●0.0%1.0%0.0%0.0%0.8%
Payout—43.5%0.0%24.2%0.0%0.0%13.5%
Valuation
MetricASPNSWIMJBINXAPOGLMBInd. Median
P/E—80.3716.48—12.05●28.0224.76
P/B2.011.731.271.00●1.614.742.49
EV/EBITDA—7.853.34●—6.9715.6415.06
P/S1.861.250.790.39●0.591.431.51
Financial Health
MetricASPNSWIMJBINXAPOGLMBInd. Median
Current Ratio2.88●1.882.652.281.761.711.54
Debt/Equity60.3%8.5%1.1%●122.3%56.2%38.9%57.7%
NetDebt/EBITDA0.790.07-0.58-9.63●1.680.961.72
Profitability
MetricASPNSWIMJBINXAPOGLMBInd. Median
Net Margin-48.6%1.5%4.8%-13.9%4.9%5.1%●4.9%
ROE-42.4%2.2%7.9%-29.7%13.8%18.6%●8.1%
ROA-23.2%1.0%3.3%-12.0%6.1%9.3%●3.6%
EBITDA Margin-25.8%16.0%20.3%●-4.6%11.1%9.7%12.2%
Growth + Dividend
MetricASPNSWIMJBINXAPOGLMBInd. Median
Rev. Growth-47.3%8.3%-2.5%14.2%1.8%22.5%●5.1%
NI Growth——-14.5%—33.1%●-0.8%-5.3%
Div. Yield———1.8%2.4%●—0.8%
Payout———-5.7%32.7%—13.5%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ASPN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.